Alexi Bueno Soler

Placeholder Person Graphic
Alexi Bueno Soler is a Chemical Engineer who has worked in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana since 2010. Alexi focuses on the development of fermentation processes at a scale of 2 and 30 liters, and the quantification of monoclonal antibodies by ELISA.

Related Articles

Figure 4: SDS-PAGE under nonreduced conditions of the fi nal purified SP Sepharose Fast Flow.
Technical
Effects of Tank-Agitated Fermentation on Therapeutic mAb Quality

Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseasesSparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061 and chronic conditions such as cancer